調査レポート | • レポートコード：QYR2104Z1824 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病治療・ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（吸入可能型インスリン、経口型インスリン、インスリンパッチ、CGMシステム、人工膵臓）、用途別市場規模（診断/クリニック、ICU、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病治療・ドラッグデリバリーの市場動向 ・企業の競争状況、市場シェア ・糖尿病治療・ドラッグデリバリーの種類別市場規模（吸入可能型インスリン、経口型インスリン、インスリンパッチ、CGMシステム、人工膵臓） ・糖尿病治療・ドラッグデリバリーの用途別市場規模（診断/クリニック、ICU、在宅医療） ・糖尿病治療・ドラッグデリバリーの北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病治療・ドラッグデリバリーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病治療・ドラッグデリバリーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病治療・ドラッグデリバリーの中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病治療・ドラッグデリバリーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind、Enteris BioPharma、Dexcom、Senseonics Holding、Medtech、Johnson & Johnson、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly、Transdermal Specialties） ・結論 |
Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market
The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Therapy and Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Therapy and Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Therapy and Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Therapy and Drug Delivery market.
Global Diabetes Therapy and Drug Delivery Scope and Market Size
Diabetes Therapy and Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Therapy and Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Segment by Application
Diagnostic/Clinics
ICUs
Home Healthcare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Novo Nordisk
MannKind
Zosano Pharma
Relmada Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Diabetes Therapy and Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Therapy and Drug Delivery Market Perspective (2016-2027)
2.2 Diabetes Therapy and Drug Delivery Growth Trends by Regions
2.2.1 Diabetes Therapy and Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Therapy and Drug Delivery Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Therapy and Drug Delivery Industry Dynamic
2.3.1 Diabetes Therapy and Drug Delivery Market Trends
2.3.2 Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue (2016-2021)
3.1.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Therapy and Drug Delivery Revenue
3.4 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapy and Drug Delivery Revenue in 2020
3.5 Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2022-2027)
5 Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetes Therapy and Drug Delivery Market Size (2016-2027)
6.2 North America Diabetes Therapy and Drug Delivery Market Size by Type
6.2.1 North America Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021)
6.2.2 North America Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027)
6.2.3 North America Diabetes Therapy and Drug Delivery Market Size by Type (2016-2027)
6.3 North America Diabetes Therapy and Drug Delivery Market Size by Application
6.3.1 North America Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021)
6.3.2 North America Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027)
6.3.3 North America Diabetes Therapy and Drug Delivery Market Size by Application (2016-2027)
6.4 North America Diabetes Therapy and Drug Delivery Market Size by Country
6.4.1 North America Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021)
6.4.2 North America Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetes Therapy and Drug Delivery Market Size (2016-2027)
7.2 Europe Diabetes Therapy and Drug Delivery Market Size by Type
7.2.1 Europe Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Therapy and Drug Delivery Market Size by Type (2016-2027)
7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Application
7.3.1 Europe Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Therapy and Drug Delivery Market Size by Application (2016-2027)
7.4 Europe Diabetes Therapy and Drug Delivery Market Size by Country
7.4.1 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Therapy and Drug Delivery Market Size (2016-2027)
9.2 Latin America Diabetes Therapy and Drug Delivery Market Size by Type
9.2.1 Latin America Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Therapy and Drug Delivery Market Size by Type (2016-2027)
9.3 Latin America Diabetes Therapy and Drug Delivery Market Size by Application
9.3.1 Latin America Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Therapy and Drug Delivery Market Size by Application (2016-2027)
9.4 Latin America Diabetes Therapy and Drug Delivery Market Size by Country
9.4.1 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Introduction
11.1.4 Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Diabetes Therapy and Drug Delivery Introduction
11.2.4 Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Diabetes Therapy and Drug Delivery Introduction
11.3.4 Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Introduction
11.4.4 Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 MannKind
11.5.1 MannKind Company Details
11.5.2 MannKind Business Overview
11.5.3 MannKind Diabetes Therapy and Drug Delivery Introduction
11.5.4 MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.5.5 MannKind Recent Development
11.6 Enteris BioPharma
11.6.1 Enteris BioPharma Company Details
11.6.2 Enteris BioPharma Business Overview
11.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Introduction
11.6.4 Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.6.5 Enteris BioPharma Recent Development
11.7 Dexcom
11.7.1 Dexcom Company Details
11.7.2 Dexcom Business Overview
11.7.3 Dexcom Diabetes Therapy and Drug Delivery Introduction
11.7.4 Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.7.5 Dexcom Recent Development
11.8 Senseonics Holding
11.8.1 Senseonics Holding Company Details
11.8.2 Senseonics Holding Business Overview
11.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Introduction
11.8.4 Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.8.5 Senseonics Holding Recent Development
11.9 Medtech
11.9.1 Medtech Company Details
11.9.2 Medtech Business Overview
11.9.3 Medtech Diabetes Therapy and Drug Delivery Introduction
11.9.4 Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.9.5 Medtech Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Introduction
11.10.4 Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Synertech
11.11.1 Synertech Company Details
11.11.2 Synertech Business Overview
11.11.3 Synertech Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.11.5 Synertech Recent Development
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Details
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.12.5 Zosano Pharma Recent Development
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Details
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.13.5 Relmada Therapeutics Recent Development
11.14 Eli Lilly
11.14.1 Eli Lilly Company Details
11.14.2 Eli Lilly Business Overview
11.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.14.5 Eli Lilly Recent Development
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Details
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021)
11.15.5 Transdermal Specialties Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Inhalable Insulin
Table 3. Key Players of Oral Insulin
Table 4. Key Players of Insulin Patches
Table 5. Key Players of CGM Systems
Table 6. Key Players of Artificial Pancreas
Table 7. Global Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetes Therapy and Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Diabetes Therapy and Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Diabetes Therapy and Drug Delivery Market Share by Regions (2016-2021)
Table 11. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Diabetes Therapy and Drug Delivery Market Share by Regions (2022-2027)
Table 13. Diabetes Therapy and Drug Delivery Market Trends
Table 14. Diabetes Therapy and Drug Delivery Market Drivers
Table 15. Diabetes Therapy and Drug Delivery Market Challenges
Table 16. Diabetes Therapy and Drug Delivery Market Restraints
Table 17. Global Diabetes Therapy and Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Diabetes Therapy and Drug Delivery Market Share by Players (2016-2021)
Table 19. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2020)
Table 20. Ranking of Global Top Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Diabetes Therapy and Drug Delivery Product Solution and Service
Table 24. Date of Enter into Diabetes Therapy and Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2016-2021)
Table 28. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Diabetes Therapy and Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2016-2021)
Table 32. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Diabetes Therapy and Drug Delivery Product
Table 67. Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Medtronic Company Details
Table 70. Medtronic Business Overview
Table 71. Medtronic Diabetes Therapy and Drug Delivery Product
Table 72. Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 73. Medtronic Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Diabetes Therapy and Drug Delivery Product
Table 77. Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Novo Nordisk Company Details
Table 80. Novo Nordisk Business Overview
Table 81. Novo Nordisk Diabetes Therapy and Drug Delivery Product
Table 82. Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 83. Novo Nordisk Recent Development
Table 84. MannKind Company Details
Table 85. MannKind Business Overview
Table 86. MannKind Diabetes Therapy and Drug Delivery Product
Table 87. MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 88. MannKind Recent Development
Table 89. Enteris BioPharma Company Details
Table 90. Enteris BioPharma Business Overview
Table 91. Enteris BioPharma Diabetes Therapy and Drug Delivery Product
Table 92. Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 93. Enteris BioPharma Recent Development
Table 94. Dexcom Company Details
Table 95. Dexcom Business Overview
Table 96. Dexcom Diabetes Therapy and Drug Delivery Product
Table 97. Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 98. Dexcom Recent Development
Table 99. Senseonics Holding Company Details
Table 100. Senseonics Holding Business Overview
Table 101. Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 102. Senseonics Holding Recent Development
Table 103. Medtech Company Details
Table 104. Medtech Business Overview
Table 105. Medtech Diabetes Therapy and Drug Delivery Product
Table 106. Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 107. Medtech Recent Development
Table 108. Johnson & Johnson Company Details
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson Diabetes Therapy and Drug Delivery Product
Table 111. Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 112. Johnson & Johnson Recent Development
Table 113. Synertech Company Details
Table 114. Synertech Business Overview
Table 115. Synertech Diabetes Therapy and Drug Delivery Product
Table 116. Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 117. Synertech Recent Development
Table 118. Zosano Pharma Company Details
Table 119. Zosano Pharma Business Overview
Table 120. Zosano Pharma Diabetes Therapy and Drug Delivery Product
Table 121. Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 122. Zosano Pharma Recent Development
Table 123. Relmada Therapeutics Company Details
Table 124. Relmada Therapeutics Business Overview
Table 125. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product
Table 126. Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 127. Relmada Therapeutics Recent Development
Table 128. Eli Lilly Company Details
Table 129. Eli Lilly Business Overview
Table 130. Eli Lilly Diabetes Therapy and Drug Delivery Product
Table 131. Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 132. Eli Lilly Recent Development
Table 133. Transdermal Specialties Company Details
Table 134. Transdermal Specialties Business Overview
Table 135. Transdermal Specialties Diabetes Therapy and Drug Delivery Product
Table 136. Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2016-2021) & (US$ Million)
Table 137. Transdermal Specialties Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Therapy and Drug Delivery Market Share by Type: 2020 VS 2027
Figure 2. Inhalable Insulin Features
Figure 3. Oral Insulin Features
Figure 4. Insulin Patches Features
Figure 5. CGM Systems Features
Figure 6. Artificial Pancreas Features
Figure 7. Global Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2027
Figure 8. Diagnostic/Clinics Case Studies
Figure 9. ICUs Case Studies
Figure 10. Home Healthcare Case Studies
Figure 11. Diabetes Therapy and Drug Delivery Report Years Considered
Figure 12. Global Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Diabetes Therapy and Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Diabetes Therapy and Drug Delivery Market Share by Regions: 2020 VS 2027
Figure 15. Global Diabetes Therapy and Drug Delivery Market Share by Regions (2022-2027)
Figure 16. Global Diabetes Therapy and Drug Delivery Market Share by Players in 2020
Figure 17. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Diabetes Therapy and Drug Delivery Revenue in 2020
Figure 19. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 20. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2022-2027)
Figure 21. North America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Diabetes Therapy and Drug Delivery Market Share by Type (2016-2027)
Figure 23. North America Diabetes Therapy and Drug Delivery Market Share by Application (2016-2027)
Figure 24. North America Diabetes Therapy and Drug Delivery Market Share by Country (2016-2027)
Figure 25. United States Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Diabetes Therapy and Drug Delivery Market Share by Type (2016-2027)
Figure 29. Europe Diabetes Therapy and Drug Delivery Market Share by Application (2016-2027)
Figure 30. Europe Diabetes Therapy and Drug Delivery Market Share by Country (2016-2027)
Figure 31. Germany Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Diabetes Therapy and Drug Delivery Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Diabetes Therapy and Drug Delivery Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Diabetes Therapy and Drug Delivery Market Share by Region (2016-2027)
Figure 41. China Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Diabetes Therapy and Drug Delivery Market Share by Type (2016-2027)
Figure 49. Latin America Diabetes Therapy and Drug Delivery Market Share by Application (2016-2027)
Figure 50. Latin America Diabetes Therapy and Drug Delivery Market Share by Country (2016-2027)
Figure 51. Mexico Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Diabetes Therapy and Drug Delivery Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Diabetes Therapy and Drug Delivery Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Diabetes Therapy and Drug Delivery Market Share by Country (2016-2027)
Figure 57. Turkey Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Diabetes Therapy and Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 63. Novo Nordisk Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 64. MannKind Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 65. Enteris BioPharma Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 66. Dexcom Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 67. Senseonics Holding Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 68. Medtech Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 70. Synertech Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 71. Zosano Pharma Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 72. Relmada Therapeutics Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 73. Eli Lilly Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 74. Transdermal Specialties Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の次世代糖尿病治療＆ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …- 世界の糖尿病用非インスリン療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 54930 million by 2026, from US$ 30040 million in 2019, at a CAGR of 8.9% during 2021-2026. With industry-standard accuracy in analysis an…
- 世界の糖尿病管理における人工知能（AI）市場規模・現状・予測（2021年-2027年） Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such …
- 世界の糖尿病管理における人工知能（AI）市場規模・現状・予測（2021年-2027年） Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such …
- 世界の非インスリンパッチポンプ市場 2021：企業別、地域別、種類・用途別 The Non-insulin Patch Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…